David Nesbitt
Concepts (273)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Riboswitch | 15 | 2025 | 60 | 7.460 |
Why?
| | Thermodynamics | 25 | 2025 | 421 | 5.370 |
Why?
| | Nucleic Acid Conformation | 30 | 2025 | 719 | 5.140 |
Why?
| | Fluorescence Resonance Energy Transfer | 20 | 2025 | 173 | 4.630 |
Why?
| | RNA Folding | 13 | 2024 | 35 | 4.420 |
Why?
| | RNA | 16 | 2025 | 922 | 3.480 |
Why?
| | Kinetics | 29 | 2025 | 1635 | 2.960 |
Why?
| | DNA | 7 | 2025 | 1441 | 2.390 |
Why?
| | Lysine | 7 | 2024 | 288 | 2.250 |
Why?
| | Temperature | 13 | 2025 | 669 | 2.060 |
Why?
| | Quantum Theory | 7 | 2012 | 88 | 1.710 |
Why?
| | Nucleic Acids | 3 | 2021 | 70 | 1.710 |
Why?
| | Manganese | 3 | 2022 | 56 | 1.400 |
Why?
| | Magnesium | 4 | 2019 | 155 | 1.280 |
Why?
| | Aptamers, Nucleotide | 3 | 2023 | 82 | 1.140 |
Why?
| | Bacillus subtilis | 3 | 2024 | 63 | 1.120 |
Why?
| | Surface Plasmon Resonance | 3 | 2012 | 87 | 1.100 |
Why?
| | Entropy | 6 | 2021 | 40 | 1.090 |
Why?
| | Sodium | 5 | 2023 | 199 | 1.080 |
Why?
| | Ligands | 7 | 2023 | 661 | 0.980 |
Why?
| | Amino Acids | 2 | 2020 | 493 | 0.980 |
Why?
| | Nanotechnology | 2 | 2021 | 123 | 0.930 |
Why?
| | Thermotoga maritima | 1 | 2024 | 12 | 0.890 |
Why?
| | Base Sequence | 12 | 2024 | 2168 | 0.880 |
Why?
| | G-Quadruplexes | 1 | 2023 | 19 | 0.820 |
Why?
| | Metal Nanoparticles | 2 | 2012 | 84 | 0.730 |
Why?
| | Quantum Dots | 2 | 2013 | 37 | 0.710 |
Why?
| | Gold | 2 | 2012 | 118 | 0.690 |
Why?
| | Molecular Dynamics Simulation | 3 | 2012 | 241 | 0.680 |
Why?
| | Osmotic Pressure | 1 | 2020 | 35 | 0.670 |
Why?
| | Vinyl Compounds | 2 | 2012 | 6 | 0.660 |
Why?
| | Gases | 3 | 2010 | 48 | 0.650 |
Why?
| | Bromovirus | 2 | 2018 | 4 | 0.630 |
Why?
| | Carbon Dioxide | 2 | 2012 | 266 | 0.590 |
Why?
| | Hot Temperature | 1 | 2021 | 391 | 0.580 |
Why?
| | Models, Molecular | 7 | 2023 | 1591 | 0.580 |
Why?
| | Molecular Conformation | 5 | 2021 | 147 | 0.540 |
Why?
| | DNA Primers | 1 | 2018 | 506 | 0.530 |
Why?
| | Oligodeoxyribonucleotides | 2 | 2014 | 142 | 0.500 |
Why?
| | Cognitive Dysfunction | 4 | 2023 | 389 | 0.490 |
Why?
| | Potassium | 3 | 2023 | 142 | 0.480 |
Why?
| | Diffusion | 4 | 2018 | 120 | 0.470 |
Why?
| | Spectrophotometry, Infrared | 3 | 2011 | 54 | 0.460 |
Why?
| | Osmosis | 1 | 2015 | 14 | 0.460 |
Why?
| | Vibration | 4 | 2012 | 73 | 0.450 |
Why?
| | Microscopy, Confocal | 2 | 2014 | 321 | 0.450 |
Why?
| | Hydroxocobalamin | 1 | 2014 | 26 | 0.440 |
Why?
| | Supranuclear Palsy, Progressive | 3 | 2025 | 18 | 0.440 |
Why?
| | Pressure | 3 | 2025 | 222 | 0.430 |
Why?
| | Infrared Rays | 1 | 2014 | 26 | 0.430 |
Why?
| | Cations | 4 | 2020 | 83 | 0.420 |
Why?
| | Urea | 1 | 2014 | 79 | 0.420 |
Why?
| | Selenium Compounds | 1 | 2013 | 21 | 0.420 |
Why?
| | Nucleotide Motifs | 1 | 2013 | 35 | 0.410 |
Why?
| | Cadmium Compounds | 1 | 2013 | 32 | 0.410 |
Why?
| | Nanostructures | 1 | 2013 | 109 | 0.380 |
Why?
| | DNA, Single-Stranded | 1 | 2013 | 120 | 0.380 |
Why?
| | Silver | 1 | 2012 | 38 | 0.380 |
Why?
| | Anions | 1 | 2012 | 31 | 0.380 |
Why?
| | Microscopy, Fluorescence | 1 | 2014 | 408 | 0.380 |
Why?
| | RNA, Viral | 1 | 2015 | 682 | 0.360 |
Why?
| | gamma-Aminobutyric Acid | 2 | 2025 | 194 | 0.360 |
Why?
| | Telomerase | 1 | 2014 | 248 | 0.360 |
Why?
| | Microscopy, Polarization | 1 | 2011 | 31 | 0.350 |
Why?
| | Frontotemporal Dementia | 2 | 2022 | 57 | 0.350 |
Why?
| | Particle Size | 4 | 2013 | 391 | 0.350 |
Why?
| | Alkynes | 1 | 2011 | 57 | 0.340 |
Why?
| | Nanotubes | 1 | 2011 | 47 | 0.340 |
Why?
| | Imidazoles | 1 | 2012 | 235 | 0.340 |
Why?
| | Nerve Net | 4 | 2021 | 262 | 0.330 |
Why?
| | Inverted Repeat Sequences | 2 | 2020 | 17 | 0.330 |
Why?
| | Ethers | 1 | 2010 | 19 | 0.320 |
Why?
| | Nucleic Acid Hybridization | 2 | 2020 | 188 | 0.320 |
Why?
| | Surface Properties | 4 | 2012 | 409 | 0.310 |
Why?
| | Magnetoencephalography | 7 | 2025 | 150 | 0.310 |
Why?
| | Cations, Monovalent | 2 | 2023 | 6 | 0.300 |
Why?
| | Squalene | 1 | 2008 | 7 | 0.300 |
Why?
| | Fluorine | 1 | 2008 | 16 | 0.300 |
Why?
| | Carbocyanines | 3 | 2019 | 32 | 0.300 |
Why?
| | Radiometry | 1 | 2009 | 49 | 0.300 |
Why?
| | Models, Neurological | 2 | 2021 | 245 | 0.290 |
Why?
| | Fluorocarbons | 1 | 2010 | 118 | 0.280 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 2008 | 85 | 0.280 |
Why?
| | Phenols | 1 | 2008 | 104 | 0.270 |
Why?
| | Ions | 2 | 2022 | 67 | 0.270 |
Why?
| | Proteins | 2 | 2014 | 1003 | 0.270 |
Why?
| | Photons | 3 | 2012 | 72 | 0.260 |
Why?
| | Base Pairing | 2 | 2019 | 64 | 0.260 |
Why?
| | Protein Folding | 2 | 2021 | 276 | 0.260 |
Why?
| | Materials Testing | 3 | 2012 | 349 | 0.250 |
Why?
| | Spectrum Analysis | 3 | 2023 | 91 | 0.250 |
Why?
| | Free Radicals | 3 | 2012 | 113 | 0.240 |
Why?
| | Alzheimer Disease | 2 | 2022 | 567 | 0.240 |
Why?
| | Polymers | 1 | 2010 | 489 | 0.240 |
Why?
| | Models, Theoretical | 1 | 2009 | 581 | 0.230 |
Why?
| | Breath Tests | 2 | 2023 | 74 | 0.230 |
Why?
| | Beta Rhythm | 1 | 2025 | 23 | 0.230 |
Why?
| | Fluorescent Dyes | 2 | 2019 | 315 | 0.230 |
Why?
| | Frontotemporal Lobar Degeneration | 1 | 2025 | 18 | 0.230 |
Why?
| | Algorithms | 2 | 2012 | 1700 | 0.230 |
Why?
| | Rotation | 3 | 2010 | 118 | 0.220 |
Why?
| | Nucleic Acid Denaturation | 2 | 2014 | 32 | 0.220 |
Why?
| | Fluorescence | 2 | 2015 | 157 | 0.210 |
Why?
| | Dissociative Disorders | 2 | 2014 | 24 | 0.210 |
Why?
| | Electromagnetic Fields | 2 | 2012 | 25 | 0.200 |
Why?
| | Single Molecule Imaging | 1 | 2022 | 36 | 0.190 |
Why?
| | Electrons | 2 | 2012 | 88 | 0.190 |
Why?
| | Calorimetry, Differential Scanning | 1 | 2021 | 37 | 0.180 |
Why?
| | Calorimetry | 1 | 2021 | 70 | 0.180 |
Why?
| | Hydrogen Bonding | 2 | 2019 | 167 | 0.180 |
Why?
| | Cognitive Aging | 1 | 2021 | 15 | 0.170 |
Why?
| | Stereoisomerism | 2 | 2012 | 98 | 0.170 |
Why?
| | Hydrostatic Pressure | 1 | 2020 | 30 | 0.170 |
Why?
| | Cobalt | 1 | 2020 | 51 | 0.170 |
Why?
| | Polymorphism, Genetic | 1 | 2023 | 634 | 0.170 |
Why?
| | Nickel | 1 | 2020 | 61 | 0.160 |
Why?
| | Neurodegenerative Diseases | 1 | 2022 | 138 | 0.160 |
Why?
| | Hydroxyl Radical | 2 | 2018 | 93 | 0.160 |
Why?
| | Auditory Cortex | 1 | 2020 | 42 | 0.160 |
Why?
| | Brain | 3 | 2022 | 2711 | 0.160 |
Why?
| | Cognition Disorders | 1 | 2023 | 502 | 0.150 |
Why?
| | Molecular Sequence Data | 4 | 2015 | 2900 | 0.150 |
Why?
| | Friction | 1 | 2018 | 14 | 0.150 |
Why?
| | Frailty | 1 | 2022 | 170 | 0.150 |
Why?
| | Frontal Lobe | 1 | 2020 | 154 | 0.150 |
Why?
| | Viscosity | 1 | 2018 | 92 | 0.140 |
Why?
| | Tetrahymena | 2 | 2009 | 157 | 0.140 |
Why?
| | Chemistry Techniques, Synthetic | 1 | 2018 | 14 | 0.140 |
Why?
| | Healthy Aging | 1 | 2018 | 35 | 0.140 |
Why?
| | Cerebral Cortex | 1 | 2021 | 433 | 0.140 |
Why?
| | Staining and Labeling | 1 | 2018 | 153 | 0.140 |
Why?
| | Nucleotides | 1 | 2018 | 125 | 0.130 |
Why?
| | Arginine | 1 | 2018 | 260 | 0.130 |
Why?
| | White Matter | 1 | 2018 | 143 | 0.130 |
Why?
| | Coenzymes | 1 | 2016 | 19 | 0.120 |
Why?
| | Lasers | 2 | 2023 | 129 | 0.120 |
Why?
| | Vitamin B 12 | 1 | 2016 | 125 | 0.120 |
Why?
| | Sensitivity and Specificity | 3 | 2023 | 1923 | 0.120 |
Why?
| | Neural Pathways | 1 | 2017 | 296 | 0.110 |
Why?
| | Isotope Labeling | 1 | 2015 | 80 | 0.110 |
Why?
| | RNA, Transfer | 1 | 2015 | 139 | 0.110 |
Why?
| | Metals | 1 | 2015 | 138 | 0.110 |
Why?
| | Immobilized Nucleic Acids | 1 | 2014 | 1 | 0.110 |
Why?
| | Heating | 1 | 2014 | 23 | 0.110 |
Why?
| | Zinc Compounds | 1 | 2013 | 7 | 0.110 |
Why?
| | Digestive System Surgical Procedures | 1 | 2014 | 103 | 0.110 |
Why?
| | Computer Simulation | 2 | 2009 | 982 | 0.110 |
Why?
| | Solutions | 1 | 2014 | 167 | 0.100 |
Why?
| | Brain Mapping | 1 | 2017 | 506 | 0.100 |
Why?
| | Corpus Callosum | 1 | 2013 | 70 | 0.100 |
Why?
| | Minimally Invasive Surgical Procedures | 1 | 2014 | 171 | 0.100 |
Why?
| | Protein Biosynthesis | 1 | 2016 | 425 | 0.100 |
Why?
| | Rectal Neoplasms | 1 | 2014 | 143 | 0.100 |
Why?
| | Aging | 2 | 2022 | 1849 | 0.100 |
Why?
| | Cognition | 1 | 2021 | 1171 | 0.100 |
Why?
| | Sulfides | 1 | 2013 | 80 | 0.100 |
Why?
| | Robotic Surgical Procedures | 1 | 2014 | 137 | 0.100 |
Why?
| | Scattering, Radiation | 1 | 2012 | 101 | 0.100 |
Why?
| | Transcription, Genetic | 2 | 2016 | 1452 | 0.100 |
Why?
| | Hydrogen | 1 | 2012 | 73 | 0.090 |
Why?
| | Transition Temperature | 1 | 2012 | 27 | 0.090 |
Why?
| | Atrophy | 2 | 2023 | 188 | 0.090 |
Why?
| | Oligoribonucleotides | 1 | 2012 | 52 | 0.090 |
Why?
| | Energy Transfer | 1 | 2012 | 47 | 0.090 |
Why?
| | RNA, Bacterial | 1 | 2012 | 188 | 0.090 |
Why?
| | GABA Uptake Inhibitors | 2 | 2021 | 5 | 0.090 |
Why?
| | Bipolar Disorder | 1 | 2013 | 263 | 0.090 |
Why?
| | Neurons | 1 | 2020 | 1586 | 0.090 |
Why?
| | Parkinson Disease | 1 | 2017 | 542 | 0.080 |
Why?
| | Magnetic Resonance Imaging | 5 | 2022 | 3574 | 0.080 |
Why?
| | Macromolecular Substances | 1 | 2011 | 226 | 0.080 |
Why?
| | Onium Compounds | 1 | 2010 | 8 | 0.080 |
Why?
| | Aged | 7 | 2025 | 23803 | 0.080 |
Why?
| | Water | 1 | 2012 | 465 | 0.080 |
Why?
| | Absorption | 1 | 2008 | 59 | 0.070 |
Why?
| | RNA, Messenger | 2 | 2016 | 2788 | 0.070 |
Why?
| | Binding Sites | 1 | 2012 | 1310 | 0.070 |
Why?
| | Least-Squares Analysis | 1 | 2008 | 79 | 0.070 |
Why?
| | Cross-Over Studies | 2 | 2021 | 547 | 0.070 |
Why?
| | Humans | 15 | 2025 | 136965 | 0.070 |
Why?
| | Static Electricity | 1 | 2008 | 117 | 0.070 |
Why?
| | Sulfonamides | 1 | 2012 | 507 | 0.070 |
Why?
| | RNA, Catalytic | 1 | 2009 | 188 | 0.070 |
Why?
| | Phase Transition | 1 | 2008 | 24 | 0.070 |
Why?
| | Adenocarcinoma | 1 | 2014 | 869 | 0.070 |
Why?
| | Aged, 80 and over | 4 | 2022 | 7559 | 0.070 |
Why?
| | Equipment Failure Analysis | 1 | 2008 | 130 | 0.070 |
Why?
| | Molecular Structure | 1 | 2008 | 493 | 0.070 |
Why?
| | Models, Chemical | 1 | 2008 | 268 | 0.070 |
Why?
| | Time Factors | 3 | 2014 | 6786 | 0.060 |
Why?
| | Cardiovascular Diseases | 1 | 2018 | 2115 | 0.060 |
Why?
| | Equipment Design | 1 | 2008 | 508 | 0.060 |
Why?
| | Magnetic Resonance Spectroscopy | 2 | 2021 | 613 | 0.060 |
Why?
| | Double-Blind Method | 2 | 2021 | 1904 | 0.060 |
Why?
| | Middle Aged | 7 | 2025 | 33226 | 0.060 |
Why?
| | Male | 9 | 2025 | 67386 | 0.050 |
Why?
| | Cohort Studies | 3 | 2021 | 5688 | 0.050 |
Why?
| | Female | 9 | 2025 | 73002 | 0.050 |
Why?
| | Postoperative Complications | 1 | 2014 | 2622 | 0.050 |
Why?
| | Protein Binding | 1 | 2009 | 2223 | 0.050 |
Why?
| | Prefrontal Cortex | 1 | 2025 | 302 | 0.050 |
Why?
| | Bayes Theorem | 1 | 2023 | 410 | 0.040 |
Why?
| | Syndrome | 1 | 2022 | 371 | 0.040 |
Why?
| | Choroid | 1 | 2001 | 62 | 0.040 |
Why?
| | Markov Chains | 1 | 2021 | 124 | 0.040 |
Why?
| | Rest | 1 | 2021 | 121 | 0.040 |
Why?
| | Neuroimaging | 1 | 2022 | 261 | 0.040 |
Why?
| | Executive Function | 1 | 2025 | 450 | 0.040 |
Why?
| | Reproducibility of Results | 1 | 2008 | 3266 | 0.040 |
Why?
| | Angiogenesis Inhibitors | 1 | 2001 | 227 | 0.040 |
Why?
| | Neovascularization, Pathologic | 1 | 2001 | 295 | 0.040 |
Why?
| | Genetic Therapy | 1 | 2001 | 297 | 0.040 |
Why?
| | Synaptic Transmission | 1 | 2021 | 289 | 0.040 |
Why?
| | Electroencephalography | 1 | 2022 | 433 | 0.040 |
Why?
| | Collagen | 1 | 2001 | 449 | 0.040 |
Why?
| | Uracil | 1 | 2018 | 31 | 0.040 |
Why?
| | Isotopes | 1 | 2018 | 34 | 0.040 |
Why?
| | Biotin | 1 | 2018 | 28 | 0.040 |
Why?
| | Peptide Fragments | 1 | 2001 | 690 | 0.030 |
Why?
| | Young Adult | 3 | 2021 | 13218 | 0.030 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2018 | 154 | 0.030 |
Why?
| | Statistics, Nonparametric | 1 | 2017 | 420 | 0.030 |
Why?
| | Templates, Genetic | 1 | 2015 | 63 | 0.030 |
Why?
| | Automation | 1 | 2015 | 94 | 0.030 |
Why?
| | Heart Rate | 1 | 2018 | 794 | 0.030 |
Why?
| | Adolescent | 3 | 2021 | 21471 | 0.030 |
Why?
| | Lithium Compounds | 1 | 2013 | 11 | 0.030 |
Why?
| | Antimanic Agents | 1 | 2013 | 18 | 0.030 |
Why?
| | Robotics | 1 | 2015 | 85 | 0.030 |
Why?
| | Nerve Fibers, Myelinated | 1 | 2013 | 47 | 0.030 |
Why?
| | Biosensing Techniques | 1 | 2015 | 133 | 0.030 |
Why?
| | In Vitro Techniques | 1 | 2015 | 1085 | 0.030 |
Why?
| | Adenine | 1 | 2015 | 293 | 0.020 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2017 | 746 | 0.020 |
Why?
| | Risk Factors | 2 | 2018 | 10363 | 0.020 |
Why?
| | Neuropsychological Tests | 1 | 2017 | 1046 | 0.020 |
Why?
| | Oxygen | 1 | 2017 | 946 | 0.020 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2013 | 549 | 0.020 |
Why?
| | Blood Pressure | 1 | 2018 | 1786 | 0.020 |
Why?
| | Adult | 3 | 2021 | 37715 | 0.020 |
Why?
| | Neoplasm Staging | 1 | 2014 | 1352 | 0.020 |
Why?
| | Feasibility Studies | 1 | 2014 | 965 | 0.020 |
Why?
| | Laparoscopy | 1 | 2014 | 434 | 0.020 |
Why?
| | Biomarkers | 1 | 2021 | 4095 | 0.020 |
Why?
| | Body Mass Index | 1 | 2018 | 2416 | 0.020 |
Why?
| | Length of Stay | 1 | 2014 | 1192 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2017 | 2809 | 0.020 |
Why?
| | Sex Characteristics | 1 | 2013 | 766 | 0.020 |
Why?
| | Animals | 2 | 2008 | 36882 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 5530 | 0.020 |
Why?
| | Exercise | 1 | 2018 | 2064 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2016 | 2574 | 0.020 |
Why?
| | Prognosis | 1 | 2014 | 3931 | 0.020 |
Why?
| | Age Factors | 1 | 2013 | 3258 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2013 | 3556 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2014 | 5048 | 0.010 |
Why?
| | Oligonucleotides | 1 | 2006 | 147 | 0.010 |
Why?
| | Endostatins | 1 | 2001 | 10 | 0.010 |
Why?
| | Ocular Physiological Phenomena | 1 | 2001 | 9 | 0.010 |
Why?
| | Collagen Type XVIII | 1 | 2001 | 5 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2006 | 2015 | 0.010 |
Why?
| | Injections, Intravenous | 1 | 2001 | 197 | 0.010 |
Why?
| | Genes, Reporter | 1 | 2001 | 271 | 0.010 |
Why?
| | Adenoviridae | 1 | 2001 | 194 | 0.010 |
Why?
| | Recombination, Genetic | 1 | 2001 | 207 | 0.010 |
Why?
| | Genetic Vectors | 1 | 2001 | 321 | 0.010 |
Why?
| | Models, Biological | 1 | 2006 | 1780 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2014 | 15536 | 0.010 |
Why?
| | Gene Expression | 1 | 2001 | 1480 | 0.010 |
Why?
| | Child | 1 | 2013 | 21760 | 0.010 |
Why?
| | Liver | 1 | 2001 | 1867 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2001 | 5733 | 0.010 |
Why?
| | Mice | 1 | 2001 | 17705 | 0.000 |
Why?
|
|
Nesbitt's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|